The use of 18-fluoro-dihydroxyphenylalanine and 18-fluorodeoxyglucose positron emission tomography scanning in the assessment of metaiodobenzylguanidine-negative phaeochromocytoma

European Journal of Endocrinology

Volumn 157, Issue 4, 2007, Pages 533-537

  Mackenzie, I S ^a   Gurnell, M ^a   Balan, K K ^a   Simpson, H ^a   Chatterjee, K ^a   Brown, M J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 6 FLUORODOPA; ADRENALIN; ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CHROMOGRANIN A; DOPAMINE; FLUORODEOXYGLUCOSE F 18; GLUCOCORTICOID; MINERALOCORTICOID; NORADRENALIN; PHENOXYBENZAMINE; SYNAPTOPHYSIN;

ADRENALECTOMY; ADRENALIN BLOOD LEVEL; ADRENALIN URINE LEVEL; ADULT; ARTICLE; CAFE AU LAIT SPOT; CANCER PALLIATIVE THERAPY; CANCER REGRESSION; CASE REPORT; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE URINE LEVEL; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DOPAMINE URINE LEVEL; ECHOGRAPHY; EPILEPSY; FOLLOW UP; HEADACHE; HEART PALPITATION; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; NEUROFIBROMATOSIS; NORADRENALIN BLOOD LEVEL; NORADRENALIN URINE LEVEL; PAPILLEDEMA; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SPINAL CORD METASTASIS; SWEATING;

3-IODOBENZYLGUANIDINE; ADRENAL GLAND NEOPLASMS; ADULT; DIHYDROXYPHENYLALANINE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; WHOLE BODY IMAGING;

EID: 35548972550     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0369     Document Type: Article

References (8)

1. Lenders JW, Eisenhofer G, Mannelli M & Pacak K. Phaeochromocytoma. Lancet 2005 366 665-675.
2. Lenders JW, Pacak K, Walther AM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS & Eisenhofer G. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 2002 287 1427-1434.
3. 18F DOPA whole body PET - initial results. Radiology 2002 222 507-512.
4. 18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension 2001 38 6-8.
5. 131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. Journal of Clinical Endocrinology and Metabolism 2003 88 4083-4087.
6. 123)I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites. Nuclear Medicine Communications 2006 27 31-36.
7. Nilsson O, Jakobsen AM, Kolby L, Bernhardt P, Forssell-Aronsson E & Ahlman H. Importance of vesicle proteins in the diagnosis and treatment of neuroendocrine tumors. Annals of the New York Academy of Sciences 2004 1014 280-283.
8. Brown MJ, Mackenzie IS, Ashby MJ, Balan KK & Appleton DS. AT2 receptor stimulation may halt progression of pheochromocytoma. Annals of the New York Academy of Sciences 2006 1073 436-443.